Skip to main content
. 2018 May;97:14–19. doi: 10.1016/j.jclinepi.2018.02.002

Table 2.

Compliance and loss to follow-up in re-randomization trials

Number of trials reporting measure Median (range)
Percent of episodes not complying with treatment protocol 5 1.7 (0–8.9)
Percent of episodes excluded from analysis due to missing data
 Overall mortality 5 0 (0–0)
 Infection-related mortality 4 0 (0–0)
 Hospitalization >10 days 3 0 (0–0)
 Duration of grade IV neutropenia 2 0 (0–0)
 Time to recovery from fever 3 0 (0–0)